Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Insomnia Disorder
Interventions
DRUG

YZJ-1139

YZJ-1139 20mg tablets, once daily in the evening

DRUG

Zolpidem

Zolpidem 10mg tablets, once daily in the evening

Trial Locations (16)

Unknown

RECRUITING

Peking University People's Hospital, Beijing

RECRUITING

ChengDu Second People's Hospital, Chengdu

RECRUITING

ChongQing Traditional Chinese Medicine Hospital, Chongqing

RECRUITING

Deyang People's Hospital, Deyang

RECRUITING

The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital), Guangzhou

RECRUITING

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital), Jinan

RECRUITING

The Second Affiliated Hospital Of NanChang University, Nanchang

RECRUITING

The First Affiliated Hospital of Ningbo University, Ningbo

RECRUITING

ShengJing Hospital Of China Medical University, Shenyang

RECRUITING

The Third Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

SuZhou GuangJi Hospital, Suzhou

RECRUITING

The Second Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Tianjin Anding Hospital, Tianjin

RECRUITING

Wuhan No.1 Hospital, Wuhan

RECRUITING

Yan'an University Xianyang Hospital, Yan’an

RECRUITING

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY